Hadron Therapy Market Insights, Forecast to 2025

David Zhaa

Hadron Therapy Market Insights, Forecast to 2025

The global Hadron Therapy market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Hadron Therapy market based on company, product type, end user and key regions.

Radiation therapy is the medical use of ionizing radiation to treat cancer. In conventional radiation therapy, beams of X rays (high energy photons) are produced by accelerated electrons and then delivered to the patient to destroy tumour cells. Using crossing beams from many angles, radiation oncologists irradiate the tumour target while trying to spare the surrounding normal tissues. Inevitably some radiation dose is always deposited in the healthy tissues.
When the irradiating beams are made of charged particles (protons and other ions, such as carbon), radiation therapy is called hadrontherapy. The strength of hadrontherapy lies in the unique physical and radiobiological properties of these particles; they can penetrate the tissues with little diffusion and deposit the maximum energy just before stopping. This allows a precise definition of the specific region to be irradiated. The peaked shape of the hadron energy deposition is called Bragg peak and has become the symbol of hadrontherapy. With the use of hadrons the tumour can be irradiated while the damage to healthy tissues is less than with X-rays.

The idea of using protons for cancer treatment was first proposed in 1946 by the physicist Robert Wilson, who later became the founder and first director of the Fermi National Accelerator Laboratory (Fermilab) near Chicago. The first patients were treated in the 1950s in nuclear physics research facilities by means of non-dedicated accelerators. Initially, the clinical applications were limited to few parts of the body, as accelerators were not powerful enough to allow protons to penetrate deep in the tissues.

In the late 1970s improvements in accelerator technology, coupled with advances in medical imaging and computing, made proton therapy a viable option for routine medical applications. However, it has only been since the beginning of the 1990s that proton facilities have been established in clinical settings, the first one being in Loma Linda, USA. Currrently about thirty proton centres are either in operation or in construction worldwide.

Report Sample includes:
- Table of Contents
- List of Tables & Figures
- Charts
- Research Methodology

Get FREE Sample of Hadron Therapy Market Report

This report studies the global market size of Hadron Therapy in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Hadron Therapy in these regions.

This research report categorizes the global Hadron Therapy market by top players/brands, region, type and end user. This report also studies the global Hadron Therapy market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

Koninklijke Philips N.V.
Advanced Oncotherapy
Varian Medical Systems
Optivus Proton Therapy
Hitachi, Ltd.
Mevion Medical Systems
ProTom International
Mitsubishi Electric Corporation
Sumitomo Corporation
ProNova Solutions, LLC

Market size by Product

Electron Beam
Proton Beam
Neutron Beam
Carbon Ion Beam
Alpha Particle Beam
Beta Particle Beam

Market size by End User

Pediatric Cancer
Bone and Soft Tissue Cancer
Prostate Cancer
Lung Cancer
Liver Cancer
Eye Cancer
Head & Neck Cancer
Others Applications (Renal Cell Carcinoma, Cervical, Gastric, and Lymphoma)

Market size by Region

North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:

To study and analyze the global Hadron Therapy market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Hadron Therapy market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Hadron Therapy companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Hadron Therapy submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Hadron Therapy are as follows:

History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Hadron Therapy market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Get the Complete Report & TOC of Hadron Therapy Market

CONTACT US:
276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170
Email: [email protected]

Follow Us On linkedin :- https://www.linkedin.com/company/24-market-reports

David Zhaa

The Global Bacteriophage Therapy Market Growth Accelerated By Use Of Viruses To Fight Bacterial Infections

kiran gire 2024-01-10

The demand for bacteriophage therapy has grown in recent years due to the rise of antibiotic-resistant "superbugs" and need for novel treatment options. The global Bacteriophage Therapy Market is estimated to be valued at US$ 1280. As antibiotic resistance continues to rise globally, bacteriophage therapy is gaining more attention from healthcare practitioners and investors. Segment Analysis The global bacteriophage therapy market is segmented based on product type, application, end-user, and geography. The global Bacteriophage Therapy Market is estimated to be valued at US$ 1280. The company is conducting various research activities and clinical trials to evaluate the efficacy of bacteriophage therapy.

Gene Therapy Market Research, Agency, Business Opportunities with New Players

nilesh 2021-11-25

The gene therapy is mainly of two types, somatic gene therapy, and germline gene therapy, depending on the type of cells its targets. The global gene therapy market is currently dominated by several market players. com/sample_request/8399 Key PlayersSome of the key players in the global gene therapy market are Amgen, Inc. The global gene therapy market has on the basis of indication is segmented, into oncology, genetic diseases/ disorders, and others. com/reports/gene-therapy-market-8399 About Market Research Future:At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services.

Gene Therapy Market Key Leaders, Emerging Technology, future 2027

nilesh 2022-03-11

The global gene therapy market is currently dominated by several market players. The gene therapy is mainly of two types, somatic gene therapy, and germline gene therapy, depending on the type of cells its targets. The global gene therapy market has on the basis of indication is segmented, into oncology, genetic diseases/ disorders, and others. The gene therapy market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. com/reports/gene-therapy-market-8399 About Market Research Future:At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services.

Gene Therapy Market 2022: New Trends, Drivers and Restraints

Biswadeep 2022-02-15

TBRC’s market report includes a chapter on the COVID-19 impact on the gene therapy industry, which gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market and how companies can strategize to bounce back from it. With updated market numbers according to the effects of the coronavirus, the report provides the most accurate expected gene therapy market growth numbers from 2022-2031. id=3395&type=smp The global gene therapy market is expected to grow from $5. The gene therapy market is expected to reach $21. Key Mergers And Acquisitions In The Gene Therapy Market30.

Plasma Therapy Market Key Business Strategies, Leading Industry Players, Regional Growth, Demand, Share, Challenges, Opportunities and 2027

apekshaagarwal 2022-04-01

Thus, the above-mentioned factors are anticipated to surge the growth of the global plasma therapy market in the near future. According to ABC analysis, the global plasma therapy market Share is expected to register a CAGR of ~13. The high number of disease patients in the region is a key contributor to the regional market growth. com/reports/plasma-therapy-market-10733About Market Research Future:At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Cell Therapy Market Anticipated to Expand at a Steady 2023 to 2030

Saya Bonde 2023-06-30

In this article, we will explore the transformative potential of cell therapy and its impact on healthcare. Similarly, cell therapy holds promise in the treatment of diabetes, spinal cord injuries, and autoimmune disorders. The Market report gives a precise scenario of the market to Business owners about access to long-term possibilities in the market, key industry drivers, restraints, challenges, projections, current and future market opportunities, and various market aspects. Collaboration between scientists, clinicians, regulatory bodies, and industry stakeholders is crucial for driving progress and navigating the complex landscape of cell therapy. Leading Market Players in Cell Therapy IndustryThe “Cell Therapy Market” study report will provide a valuable insight with an emphasis on the worldwide market including some of the major players such as Stempeutics Research Pvt.

WHO TO FOLLOW